Literature DB >> 7760450

Cardiac arrest following an iatrogenic 3,4-diaminopyridine intoxication in a patient with Lambert-Eaton myasthenic syndrome.

C E Boerma1, J H Rommes, R B van Leeuwen, J Bakker.   

Abstract

Syndromes with impaired neuromuscular transmission are frequently treated with pyridine derivates. 3,4-diaminopyridine is thought to have fewer side effects than the commonly used, but less potent, 4-aminopyridine. We describe a patient with an initially unrecognized iatrogenic intoxication with 3,4-diaminopyridine. Except for a life threatening arrhythmia, symptoms were similar to a 4-aminopyridine intoxication. The patient made a full recovery with symptomatic treatment and withdrawal of the drug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760450     DOI: 10.3109/15563659509017992

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  4 in total

1.  Lambert-Eaton Myasthenic Syndrome.

Authors:  John Newsom-Davis
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.598

Review 2.  4-aminopyridine toxicity: a case report and review of the literature.

Authors:  Andrew M King; Nathan B Menke; Kenneth D Katz; Anthony F Pizon
Journal:  J Med Toxicol       Date:  2012-09

3.  Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.

Authors:  Sabine Lindquist; Martin Stangel
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-30       Impact factor: 2.570

4.  The European LEMS Registry: Baseline Demographics and Treatment Approaches.

Authors:  Renato Mantegazza; Andreas Meisel; Joern P Sieb; Gwendal Le Masson; Claude Desnuelle; Mirko Essing
Journal:  Neurol Ther       Date:  2015-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.